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Background: Pterygium is a disorder of the ocular surface induced by chronic exposure to UV-light. Abundant data
is available from patients with primary pterygium, but scarce from those with recurrent pterygium. The present study
aimed to explore the oxidant/antioxidant status in tissue of primary and recurrent pterigium in men and women.
Methods: Pathological tissue samples were taken during surgery on patients with primary and recurrent pterygium.
Healthy conjunctive tissue samples were taken during cataract surgery. After homogenization of 77 tissue samples,
evaluation was made of thiobarbituric reactive substances (TBARS), nitric oxide (NO), total antioxidant status (TAS) and
the activity of the three main antioxidant enzymes: glutathione peroxidase, superoxide dismutase and catalase. Gender
differences were evaluated.
Results: Compared to the control group, in the primary pterygium group there was an increase in NO and TAS, and a
tendency to a decrease of all antioxidant enzymes, indicating an increase in non-enzymatic antioxidant activity. Compared
to the control group, in the recurrent pterygium group there was a significant decrease in the level of TAS and antioxidant
enzymes. A high positive correlation was found between most of measured parameters within the control group and the
recurrent pterygium group, but not within the primary pterygium group. Compared to men, a significant difference was
observed in the elevated NO level and low TAS level of women in the prymary pterygium group.
Conclusions: The diminished antioxidant defense in the recurrent pterygium group, possibly determined mainly by
decreased non-enzymatic activity, supports the idea that oxidative stress plays an important role in the recurrence of this
disorder.
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Pterygium is an inflammatory and degenerative process
resulting from an uncontrollable cellular proliferation of
the subconjunctival and fibrovascular connecting tissue
on the cornea. Chronic exposure to ultraviolet light, caus-
ing the excessive production of free radicals through a
photochemical reaction, is widely accepted as an import-
ant factor in the development of pterygium [1,2]. This
disease causes changes in the oxidant/antioxidant state
of the human cornea [3,4]. The molecular mechanism
by which tissue proliferation is induced is still not clear.
In a recent revision [5] a mutagenic mechanism, with* Correspondence: kormanovski@yahoo.com.mx
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article, unless otherwise stated.the participation of ROS generated by UV light, was
discussed as the principal trigger of non-cancer ocular
diseases including pterygium. On the other hand, a re-
turn of disease after the operation may be due to a non-
mutagenic mechanism. This possibility requires further
research that compares primary and recurrent pterigium.
Data about these differences were analyzed in a review
[6], which explored the role of the p53 tumor suppres-
sor [7,8], the different growth factors [9] and distinct
viruses [10,11].
In the context of primary pterygium, there are various
reports on oxidative stress and the antioxidant defense
[12-18]. Elevated levels of nitric oxide (NO) and reduced
levels of SOD and CAT have been found in the tissue of pri-
mary pterygium, which suggests the involvement of oxida-
tive stress in this pathology [15,16]. 8-hidroxideoxiguanosineentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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used to identify oxidative damage to DNA, has been found
in pterygium in some studies [12,13,18,19]. Nevertheless,
no relation has been established between 8-OHdG and
recurrent pterygium [18]. Indeed the information on
the oxidant/antioxidant state is scarce in regard to this
disorder.
In rabbit, it has been shown that consumption of anti-
oxidants as a nutritional supplement can strengthen de-
fenses against oxidative stress involved in cornea and
conjunctiva [1]. In humans this same therapy is used to
treat marginal dry eye [20]. The aim of the present study
was to compare the oxidant/antioxidant state of tissue
from primary and recurrent pterigium in men and women
of a population exposed to UV light during many days of
the year.
Methods
There were 92 patients involved in the present two-year
study, including those with healthy tissue (C), primary
pterygium (PP) and recurrent pterygium (RP). Exclusion
factors were the existence of systemic illness, immuno-
suppressive treatment, or previous ocular surgery. The
same group of doctors operated on the patients with pte-
rygium and cataracts. Based on pre-established criteria, 15
patients were excluded from the study, leaving 77 partici-
pants. In the case of recurring patients, the time between
the first and second operation varied between 2 and 8 years.
Regarding gender and age differences among patients
in the three groups, there were no significant differences
(Table 1).
The study was conducted in the Superior Medicine
School of the National Polytechnic Institute, and a hos-
pital known as Nuestra Señora de la Luz. Both institutions
are in Mexico City (altitude 2300 m). The pathological tis-
sue samples were obtained during surgery on patients with
primary and recurrent pterygium. Samples of healthy con-
junctive tissue were obtained during cataract surgery from
the nasal limbus area. All tissue samples were collected
with the patient’s consent. The protocol was approved by
the Ethics Committees of the Superior Medicine School
based on criteria’s that adhered to the tenets of the Declar-
ation of Helsinki.
Samples were immediately placed in liquid nitrogen to
await homogenization (within 4 weeks). Homogenization
of samples was carried out in cold phosphate bufferTable 1 Population data
Group n Age (male)
Control 12 60.2 ± 8.4
Primary pterygium 16 55.5 ± 8.6
Recurrent pterygium 11 47.6 ± 14.5
Gender and age of patients in the control, primary pterygium and recurrent pteryg
Values are given as the mean ± SD. n = number of patients.(30 mmol/l, pH 7.4, 0.1% Triton ×100), followed by centri-
fuging (10,000 rev/min, 15 minutes at 4°C). The super-
natant was stored at -70°C to await analysis. Total proteins
were determined within 2 weeks of homogenization by
employing Lowry’s method. Measurement was made of
thiobarbituric acid reactive substances (TBARS) [21],
nitrates/nitrites (NO) and catalase (CAT) by using Cay-
manchemistry procedures. The Randox procedure was
used to determine the total antioxidant status (TAS), as
well as glutathione peroxidase (GPx) and superoxide dis-
mutase (SOD) levels. Results are presented in nmol/mg of
total protein for TBARS, NO and TAS, and in U/mg of
total protein for the enzymes.
TAS was measured in the system that generates the
ABTS® cation radical (HX-FeIII + H2O2), with absorbance
at 600 nm. In the event of the presence of antioxidants
in stained tissue, absorbance is diminished. A syn-
thetic antioxidant (6-hydroxy-2,5,7,8-tetramethylchroman-
2-carboxylic acid) was used as the standard. Thus, the level
of TAS is equivalent to nmol/mg of total proteins of this
standard.
The software package SPSS 17.0 was used for all statis-
tical analysis. One-way ANOVA (one way) and the Tukey
test were used to analyze variables between groups, and
the Pearson correlation coefficient was employed for values
within each group. Statistical significance was considered
with p < 0.05.
Results and discussion
There were no statistical differences in the TBARS levels
between any of the groups (all patients). The level of
NO (Figure 1A) and TAS (Figure 1B) of the primary pte-
rygium group was significantly higher than the value of
these parameters for the control or recurrent pterygium
groups. The level of TAS in the recurrent pterygium group
was lower than that in the control group. For the three
principal antioxidant enzymes (GPx, SOD and CAT),
there was a tendency to lower levels in the primary pteryg-
ium than control group (Figure 1C, D, and E, respectively),
and significantly lower levels in the recurrent pterygium
than control group.
Regarding TBARS levels, there was no significant differ-
ence between groups or between genders within each
group. A significant difference existed in NO levels between
men and women of the primary pterygium group, and be-
tween women of this same group and the women of then Age (female) n Age (all)
11 54.1 ± 17.5 23 56.6 ± 17.0
15 54.0 ± 8.5 31 54.7 ± 9.1
12 53.6 ± 10.2 23 50.7 ± 13.1
ium groups.
Figure 1 All patients. Levels of NO (A), TAS (B), GPx (C), SOD (D) and CAT (E) in the three groups: control group (C); the primary pterygium
group (PP); and the recurrent pterygium group (RP). n = number of patients. * - p < 0.05, ** - p < 0.01 compared to the control group. & - p < 0.05,
& & - p < 0.01 compared PP and RP groups.
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level of NO found in all patients of the primary pterygium
was caused principally by the women of this group. There
was a higher level of TAS for both men and women in
the primary pterygium group than in the corresponding
gender of the control group (Figure 2B). Contrarily,
there was a lower level of TAS for both men and women
in the recurrent pterygium group than in the correspond-
ing gender of the control or PP group. Regarding enzym-
atic activity (Figure 2C, D, E), no gender difference was
observed within any group. However, in regard to men
was a significantly lower value of GPx in the PP and RP
groups compared to the control group (Figure 2C). Add-
itionally, in regard to women the value of SOD and CAT
was lower in the recurrent pterygium group than the con-
trol group (Figure 2D, E).
It is commonly accepted that a close relationship exists
between the parameters of oxidative stress and those ofthe antioxidant defense. We calculated the Pearson correl-
ation coefficients between the values of parameters within
each group. A correlation was not observed between two
parameters of oxidative stress (TBARS and NO) in all
groups. When comparing the values of TBARS, NO and
antioxidant parameters inside of groups, a correlation was
found in the control and recurrent pterygium group, but
not in primary pterygium group (Table 2). There seem to
be some factors that distort and/or transform this relation
in latter group. A gender difference was observed princi-
pally in the control group, where SOD activity had a posi-
tive correlation with all parameters for women, but only
with GPx for men. For men and women of the primary
pterygium group, the SOD activity only corresponded
positively to the value of CAT. For men and women of
the recurrent pterygium group, the SOD activity showed a
positive correlation with all parameters of the antioxidant
defense. Additionally, for men of this same group, the
Figure 2 Genders differences. Levels of NO (A), TAS (B), GPx (C), SOD (D) and CAT (E), in the three groups: the control group (C), the primary
pterygium group (PP) and recurrent pterygium group (RP). * - p < 0.05, ** - p < 0.01 regarding gender differences within each group; a - p < 0.05,
aa - p < 0. 01 compared to the same sex of the control group; & - p < 0.05, && - p < 0.01 when comparing the same sex between the PP and RP
groups; m =male; f = female.
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eter of oxidative stress. It seems that the high level of
correlation of SOD with other parameters in patients of
control group was mainly caused by the women of this
group.
CAT response shows the same SOD pattern in the dis-
tribution of correlations for the groups under study,
both in all the patients and in those separated by gender.
The GPx correlations were observed in the PP group in
all patients and females. No correlations were observed
between indicators of oxidant stress (NO, TBARS), and
between TAS with these indicators, except for NO in the
RP group of males.
The elevated level of NO in the primary pterygium
group compared to the control group coincides with the
data of various reports [14-16,22], although it is not in
agreement with one study [14]. This controversy was dis-
cussed in a recent study [16]. There was a clear tendencyto lower levels of the three principal antioxidant enzymes
in the primary pterygium group compared to the control
group (without showing statistical significance), as was
found in the aforementioned repot [16]. Unlike that study,
in the current contribution no significant difference was
found in the level of TBARS of the primary pterygium
group compared to the control group.
The higher level of NO in the primary pterygium group
(compared to the control group) coincides with the ele-
vated level of TAS and with the tendency to lower levels
for all three antioxidant enzymes in the same group.
For various reasons we interpret the level of TAS as the
sum of enzymatic and non-enzymatic antioxidant capacity:
(i) in the homogenized tissue, both enzymatic and non-
enzymatic antioxidant activity is present; (ii) the possibility
exists for stable free radicals (used in the methodological
procedure) to be inactivated by both non-enzymatic
and enzymatic antioxidants, as all antioxidant enzymes
Table 2 Correlation between parameters
Group n TBARS NO TAS GPX CAT
SOD (all) C 23 0.54* 0.51* 0.71** 0.69**
PP 31 0.87***
RP 23 0.55* 0.85*** 0.47* 0.86***
SOD (f) C 11 0.86** 0.62* 0.77* 0.72*
PP 15 0.88**
RP 12 0.83** 0.82** 0.85**
SOD (m) C 12 0.69*
PP 16 0.95**
RP 11 0.79* 0.69* 0.86** 0.87**
CAT (all) C 23 0.79***
PP 31
RP 23 0.48* 0.87*** 0.59*
CAT (f) C 11 0.90** 0.72*
PP 15
RP 12 0.87** 0.60*
CAT (m) C 12
PP 16 0.65*
RP 11 0.67* 0.62*
GPx (all) C 23
PP 31 0.59*
RP 23
GPx (f) C 11 0.64*
PP 15 0.84**
RP 12 0.68*
GPx (m) C 12
PP 16
RP 11
Matrix of the Pearson correlation coefficients between measured parameters
of the oxidant/antioxidant state in ocular tissue of all patients, female and
male within each group: control (C), primary pterygium (PP) and recurrent
pterygium (RP). * - p < 0.05, ** - p < 0.01, *** - p <0.001; no value – p > 0.05.
n = number of patients per group, m =males, f = females.
SOD = superoxide dismutase, CAT = catalase, GPx = glutathione peroxidase,
TAS = total antioxidant status, TBARS = thiobarbituric acid reactive substances.
NO = nitric oxide.
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of this parameter with the levels of all antioxidant en-
zymes in this study provides indirect evidence in favor
of this interpretation. Although our interpretation is
debatable, we will use it as long as there is no contrary
evidence.
Thus compared to the control group, the higher level
of TAS together with the lower level of the principal en-
zymatic antioxidant activity in the primary pterygium
group implies a higher level of non-enzymatic antioxidant
activity in this same group. Compared to the control
group, there was no significant difference in the param-
eters of oxidative stress (TBARS and NO) in the recurrentpterygium group, but the values of the parameters of the
antioxidant defense (TAS and the three enzymes) were
significantly lower in this same group. The decrease is
similar among these four parameters, varying between 30
to 40%. As there is no evidence of a decrease in the gener-
ation of ROS in this group, we can conclude that the
system of antioxidant defense in recurrent pterygium
group is strongly debilitated, at least in the enzymatic
part, compared to the control group. When comparing
the recurrent pterygium group with the primary pterygium
group, only NO and TAS were found to be significantly
lower in the former, representing 40% and 68% of the
values of the latter group, respectively. Considering that
the decrease in enzymatic activity in the recurrent group
compared to the primary group is less than 15% (p > 0.1),
it can be appreciated that the differences between these
two groups are determined mainly by non-enzymatic part
of TAS activity. If true, the patients of the recurrent
pterygium group have a deficient non-enzymatic part of
antioxidant defense compared with patients of the pri-
mary pterygium group.
Overall, the similarity in the correlations between the
different parameters in the control group and the recur-
rent pterygium group (Table 2) is quite notable, as is the
difference between these two groups and the primary
pterygium group. It is likely that greater non-enzymatic
antioxidant activity is the main factor leading to the dis-
tinct results for the latter group. Non-enzymatic antioxi-
dants can be mobilized to ocular tissues from other
organs (including the liver). For some reason the level of
vitamin C in the subconjunctival connecting tissue of the
cornea is around 1 mmol/l, higher than in any other tissue
in the human organism [3]. Whereas it is likely that pa-
tients with recurrent pterygium have already exhausted this
source of antioxidants, patients with primary pterygium
probably still have this source available.
Regarding gender differences, a significantly higher
level of NO was found in the women than men of the
primary pterygium group. The increase in NO levels in
the current contribution was smaller than that found in
a recent report [16], probably because women comprised
65% of pterygium group in that study and only 50% in
our study. The elevated level of NO could indicate a greater
level of oxidative stress, and is likely to be important for the
integral functioning of the antioxidant defense by NO me-
diated mechanism [23].
The gender difference in correlation between parame-
ters of antioxidant defense was observed principally in
the control group. SOD activity had a positive correlation
with all parameters of the antioxidant defense for the
women of this group, but showed a positive correlation
only with the value of GPx for the men. This confirms
that gender differences do indeed seem to exist in the
functioning of the antioxidant system. In the presence
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that the non-enzymatic antioxidant capacity plays a greater
role in men than women with regard to the maintenance
of oxidant/antioxidant homeostasis.
Whether the cause is the depletion of the non-
enzymatic antioxidant reserves (due to poor nutrition,
poor functioning of the digestive tract or some other
reason) or a higher degree of oxidative stress, the result is
the same— a weakening of the antioxidant system and
consequently an increase in the risk of a recurrence of
pterygium. Additionally, it cannot be ruled out that the
weakening of the antioxidant defense in the recurrent
pterygium group is due to a reduced genetic expression
of the main antioxidant enzymes, especially in people
with little physical activity.
Conclusions
The existence of a diminished antioxidant defense in the
recurrent pterygium group supports the idea that oxidative
stress plays an important role in the return of pterygium.
It is possible that the differences between two pathological
groups are determined mainly by non-enzymatic antioxi-
dant active, suggesting the importance of maintaining
the antioxidant defense of patients after surgery of primary
pterygium [5,24].
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